Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Company Interview Excerpt
JEFFREY MARGOLIS - THE TRIZETTO GROUP INC (TZIX)


Full article published: 07/21/2003


For Subscribers

Get this article online now!

Order just this article
TWST: Would you bring us up to date on company progress over the past year or so?
Mr. Margolis: Investors should note TriZetto's trend toward profitability. In fact, we expect to become EPS-positive later this year. We experienced healthy organic growth of 22% in 2002, and expect organic growth in the 13%-19% range for 2003. We've also continued to expand our sales capabilities and are doing a better job of selling our full range of offerings, including software, outsourced services and consulting.

TWST: That's solid growth in a rather sluggish economy. Where is it coming from ' particular industry segments or a broadening of your product line?
Mr. Margolis: TriZetto's growth stems from larger contracts that include more than just software. That means we're selling more services ' software hosting services; outsourced transaction services; and consulting services, which include both strategy and implementation services. That said, we continue to experience healthy sales in our software area as well. If you combine all of our products and services, we have many different ways to generate revenue and grow the business.

 

Tickers included in this excerpt: TZIX

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.